| ISCIX | TIDDX | ISCIX / TIDDX | |
| Total Expense Ratio | 0.99 | 1.08 | 92% |
| Annual Report Gross Expense Ratio | 1.30 | 1.08 | 120% |
| Fund Existence | 18 years | 10 years | - |
| Gain YTD | 5.544 | 5.888 | 94% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 500000 | 200% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 476M | 6.44B | 7% |
| Annual Yield % from dividends | 1.20 | 1.61 | 75% |
| Returns for 1 year | 28.91 | 26.44 | 109% |
| Returns for 3 years | 48.51 | 35.08 | 138% |
| Returns for 5 years | 21.92 | -12.75 | -172% |
| Returns for 10 years | 76.66 | 74.46 | 103% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| GGSYX | 17.15 | 0.12 | +0.70% |
| Grandeur Peak Global Stalwarts Instl | |||
| MYIMX | 25.47 | 0.14 | +0.55% |
| Victory Integrity Mid-Cap Value Y | |||
| FRBRX | 182.81 | 0.78 | +0.43% |
| Franklin Biotechnology Discovery R6 | |||
| FNCMX | 299.43 | N/A | N/A |
| Fidelity Nasdaq Composite Index | |||
| PAECX | 19.87 | -0.08 | -0.40% |
| Putnam Dynamic Asset Allocation Gr C | |||